1/29
07:41 am
alt
Altimmune (NASDAQ:ALT) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.
Low
Report
Altimmune (NASDAQ:ALT) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.
1/27
06:00 pm
alt
Altimmune (NASDAQ:ALT) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock.
High
Report
Altimmune (NASDAQ:ALT) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock.
1/27
04:22 pm
alt
Altimmune initiated with an Overweight at Barclays
High
Report
Altimmune initiated with an Overweight at Barclays
1/27
04:22 pm
alt
Altimmune initiated with an Overweight at Barclays
High
Report
Altimmune initiated with an Overweight at Barclays
1/27
04:11 pm
alt
Altimmune initiated with an Overweight at Barclays
High
Report
Altimmune initiated with an Overweight at Barclays
1/27
04:11 pm
alt
Altimmune initiated with an Overweight at Barclays
High
Report
Altimmune initiated with an Overweight at Barclays
11/12
08:46 am
alt
Altimmune (NASDAQ:ALT) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Altimmune (NASDAQ:ALT) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..